Skip to main content
. 2022 Jun 6;21:96. doi: 10.1186/s12933-022-01523-7

Table 5.

Associations between TyG index and CAD severity according to different glucose metabolism states

Glucose regulation state Variables Multi-vessel coronary artery disease
OR (95% CI)a P-value OR (95% CI)b P-value OR (95% CI)c P-value
NGR TyG index 1.828 (0.802–4.166) 0.151 1.747 (0.726–4.203) 0.213 1.797 (0.706–4.573) 0.219
T1 Reference Reference Reference
T2 1.292 (0.512–3.257) 0.588 1.227 (0.458–3.287) 0.684 1.329 (0.467–3.783) 0.594
T3 3.321 (0.619–17.820) 0.161 3.052 (0.529–17.608) 0.212 3.373 (0.545–25.628) 0.180
Pre-DM TyG index 0.990 (0.623–1.574) 0.966 1.055 (0.658–1.691) 0.824 0.926 (0.565–1.517) 0.182
T1 Reference Reference Reference
T2 0.918 (0.540–1.562) 0.753 0.945 (0.553–1.616) 0.837 0.868 (0.449–1.509) 0.759
T3 0.825 (0.396–1.719) 0.608 0.905 (0.430–1.908) 0.794 0.791 (0.367–1.707) 0.616
DM TyG index 1.646 (1.127–2.404) 0.010 1.721 (1.170–2.532) 0.006 1.717 (1.161–2.539) 0.007
T1 Reference Reference Reference
T2 1.191 (0.610 -2.327) 0.609 1.192 (0.609–2.334) 0.608 1.030 (0.513–2.069) 0.933
T3 2.185 (1.142–4.181) 0.018 2.273 (1.180–4.376) 0.014 2.105 (1.069–4.144) 0.031

Compared with single-vessel CAD

OR, odds ratios; CI, confidence interval; NGR, normal glucose regulation; Pre-DM, prediabetes mellitus; DM, diabetes mellitus

aModel 1: unadjusted

bModel 2: adjusted for age and sex;

cModel 3: adjusted for age, sex, SBP, DBP, BMI, smoking, drinking, and antihypertensive, antilipidemic, and antiplatelet drug therapy